Reuters logo
BRIEF-Basilea Pharmaceutica FY 2014 total operating income CHF 42.6 mln vs CHF 41.4 mln yr ago
2015年2月17日 / 早上6点28分 / 3 年前

BRIEF-Basilea Pharmaceutica FY 2014 total operating income CHF 42.6 mln vs CHF 41.4 mln yr ago

Feb 17 (Reuters) - Basilea Pharmaceutica AG :

* Says FY 2014 net loss of 41.5 million Swiss francs($44.53 million)

* FY cash and short-term investments of 226 million francs

* Says FY 2014 total operating income 42.6 million francs versus 41.4 million francs year ago

* In 2014, operating loss amounted to 41.8 million francs, compared to 33.3 million francs in 2013

* Total operating expenses for 2015 are estimated at approximately 9 million francs on average per month

* Average operating loss in 2015 is estimated at approximately 4 million francs per month Source text for Eikon: Further company coverage: ($1 = 0.9319 Swiss francs) (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below